Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia.
about
The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemiaGPHN, a novel partner gene fused to MLL in a leukemia with t(11;14)(q23;q24).Identification of chromosomal loci associated with non-P-glycoprotein-mediated multidrug resistance to topoisomerase II inhibitor in lung adenocarcinoma cell line by comparative genomic hybridization.Late toxicity following curative treatment of testicular cancer.Leukemia relapse reconsidered from the molecular aspect.Leukemias related to treatment with DNA topoisomerase II inhibitors.Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.Avoiding chemotherapy related late effects in children with curable tumoursEpipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer.'VEEP' in children with Hodgkin's disease--a regimen to decrease late sequelae.Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3,000 patients treated since 1989.Curcumin enhances the cytogenotoxic effect of etoposide in leukemia cells through induction of reactive oxygen speciesA "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Adolescents with Hodgkin lymphoma: old children or young adults?Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer.Therapy-related Acute Myeloid Leukemia after the Long-term Administration of Low-dose Etoposide for Chronic-type Adult T-cell Leukemia-lymphoma: A Case Report and Literature Review.Epidemiological and etiological aspects of myelodysplastic syndromes.Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.The challenge of acute lymphoblastic leukaemia in adults.Hematopoietic malignancies and related disorders among benzene-exposed workers in China.Multilevel therapeutic targeting by topoisomerase inhibitors.A comparative analysis of alkylating agent and epipodophyllotoxin-related leukemias.Myelodysplasia and acute myeloid leukemia occurring after autologous bone marrow transplantation for lymphoma.Development of acute megakaryoblastic leukemia with isochromosome (12p) after a primary mediastinal germ cell tumor in Korea.Molecular analysis of lambda bio transducing phage produced by oxolinic acid-induced illegitimate recombination in vivo.Evaluation for the development of 11q23 rearrangements in lymphoma patients treated with a high dose VP-16 and cyclophosphamide salvage regimen.Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.Feasibility of VECOPA, a dose-intensive chemotherapy regimen for children and adolescents with intermediate and advanced stage Hodgkin lymphoma: results of the GPOH-HD-2002/VECOPA pilot trial.
P2860
Q24545339-053B1415-A00F-45E9-8E79-F9AF76011933Q30727023-A7C59A20-0486-43D7-B390-F3E39A30915DQ31792984-5E027FFF-B78F-4885-90C2-DDD8EA3458CFQ33788925-AD495FF8-9A81-4475-A24F-24544C67ED07Q34066655-194E7597-C1D3-441F-B27D-272DB5267654Q34243503-7BC72A99-0260-48F0-8119-CFD3A5F87894Q35266795-1C6EF86E-C6CC-4B88-A672-D22AA61CFE72Q35448174-3A843B8D-8C59-45B4-B1C6-718512E00795Q35822033-30166EF8-0733-468F-90AB-FCA9CD3DC014Q35993073-DD30AC83-F940-4F54-8B5A-9881F6BE56BDQ36384679-82730CC0-B9A9-48C6-8EDF-30140AD71799Q36557734-8F4F97F6-D7A9-4474-8F74-A4252E926CFCQ37204002-22610DBD-8A49-4FCF-A51B-4383DBE76195Q37968278-3EEE3D45-E83F-46A2-B5E3-DADE8924C2C0Q38791566-E895A6A9-5147-4B3F-8450-B267D230004DQ39440364-24399E37-886C-49C5-8630-B526955E5139Q40507921-9366EC4D-055C-404F-A218-E3E8E39BF9CAQ40594608-63E132BC-5297-4923-8669-A984E1B2124EQ40626835-FBFB554E-A8E0-4873-B031-C14A21E521E4Q40628279-F9AD5B8C-0449-467F-B105-E52647E1F587Q40696510-DD617F3D-46BB-4253-A77D-9BA46F9855CEQ40771488-AD8654D2-6AD6-4A33-95A4-EEB7123A8458Q41132528-30579139-1906-47F4-927B-B54ACC696A3DQ41882855-F4E39554-3A7A-40C9-A70A-00C651AEDAE0Q42965763-BBA5E37B-F942-419E-979E-EC2C05E60979Q44509212-E79D9AD1-2D56-433F-9CEF-8C59237AEAA4Q50963043-2D0FCC1C-074D-4FFC-ABE0-9C096A81CC61Q51055628-89EA0541-8200-4086-8510-DD3A40325808
P2860
Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@ast
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@en
type
label
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@ast
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@en
altLabel
Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia
@en
prefLabel
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@ast
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@en
P2093
P1433
P1476
Epipodophyllotoxin-related leu ...... subset of secondary leukemia.
@en
P2093
P2860
P304
P356
10.1002/1097-0142(19910801)68:3<600::AID-CNCR2820680326>3.0.CO;2-F
P407
P577
1991-08-01T00:00:00Z